Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP51A1 | Q16850 | 4/20 | 0.41 |
| ▸ | CYP26A1 | O43174 | 5/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.39 |
| ▸ | FPGS | Q05932 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7706032 | 1.00 | CA2 (0.45) | CA2CA1POLBCYP51A1CYP26A1 | |
| SCHEMBL7706049 | 0.91 | AGTR2 (0.46) | CA2CA1CYP51A1CYP26A1CYP19A1 | |
| SCHEMBL7706060 | 0.91 | AGTR2 (0.46) | CA2CA1CYP51A1CYP26A1CYP19A1 | |
| SCHEMBL8617653 | 0.87 | FNTA (0.45) | CA2CA1POLBCYP51A1CYP26A1 | |
| SCHEMBL7703378 | 0.87 | FNTA (0.45) | CA2CA1POLBCYP51A1CYP26A1 | |
| SCHEMBL8617640 | 0.87 | FNTA (0.45) | CA2CA1POLBCYP51A1CYP26A1 | |
| SCHEMBL7703375 | 0.87 | FNTA (0.45) | CA2CA1POLBCYP51A1CYP26A1 | |
| SCHEMBL7703357 | 0.81 | AGTR2 (0.48) | POLBCYP51A1CYP26A1CYP19A1AGTR2 | |
| SCHEMBL7703354 | 0.81 | AGTR2 (0.48) | POLBCYP51A1CYP26A1CYP19A1AGTR2 | |
| SCHEMBL7703427 | 0.80 | AGTR2 (0.45) | POLBCYP51A1CYP19A1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6414145-B1 | TREATING CANCER AND NEUROFIBROMATOSIS | ZENECA LIMITED (GB) | 2002-07-02 | — | — | US | claimed |
| EP-0975603-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 2000-02-02 | — | — | EP | claimed |
| WO-1998032741-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 1998-07-30 | — | — | WO | claimed |
| US-6414145-B1 | TREATING CANCER AND NEUROFIBROMATOSIS | ZENECA LIMITED (GB) | 2002-07-02 | — | — | US | disclosed |
| EP-0975603-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998032741-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 1998-07-30 | — | — | WO | disclosed |